Of note, in patients with ACTG2 variants other than P39 or R40 mutations cholecystolithiasis was significantly more likely suggesting a cumulative effect of PN and visceral myopathy in MMIHS cholelithiasis. The gene discussed is ACTG2; the disease is cholelithiasis.